Argos Therapeutics, Inc. could be a weak company given it's low Piotroski F-score. The momentum for this stock is not very good. The stock will provide you with a reasonable dividend income. Argos Therapeutics, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Argos Therapeutics, Inc..